Tucows Inc. filed its unaudited third-quarter 2026 financial results on November 5, 2026, reporting consolidated net revenue of $100.0 million and Adjusted EBITDA of $18.6 million for the three months ended September 30, 2026.
Hyster-Yale, Inc. (NYSE:HY) reported its consolidated financial results for the three months ended September 30, 2026, disclosing a narrowed operating loss, a return to positive Adjusted EBITDA, and $550 million in bookings, in a filing dated November 5, 2026.
Chesapeake Utilities Corporation filed its third-quarter 2026 financial results on November 5, 2026, reporting net income of $21.6 million and diluted earnings per share of $0.89 for the three months ended September 30, 2026.
Nelnet, Inc. filed its third-quarter 2026 earnings press release on November 5, 2026, reporting GAAP net income of $76.2 million for the three months ended September 30, 2026, alongside segment results, share repurchase activity, and a declared fourth-quarter dividend.
Drilling Tools International Corporation filed an 8-K earnings press release on November 6, 2026, reporting financial results for the three months ended September 30, 2026, and providing updated full-year 2026 guidance.
Ameren Corporation (NYSE:AEE) reported third quarter 2026 GAAP net income of $676 million, or $2.42 per diluted share, and raised its full-year 2026 earnings guidance range, according to a press release filed November 5, 2026.
Carriage Services, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 5, 2026, reporting third-quarter net income of $8.880 million and diluted earnings per share of $0.56.
Comstock Resources, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter net income available to the Company of $22,270 thousand on total revenues of $384,363 thousand.
Nkarta, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the SEC on November 5, 2026, disclosing continued operating losses and no product revenue as it advances its CAR NK-cell therapy pipeline.
Amphastar Pharmaceuticals, Inc. officer William J Peters filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 12,631 shares of common stock through UBS Financial Services, Inc., with an aggregate market value of $366,189.00.